Effects of Anti-EGF Receptor Antibodies on Colon Cancer Cells
Author Information
Author(s): Liu B, Fang M, Schmidt M, Lu Y, Mendelsohn J, Fan Z
Primary Institution: The University of Texas M. D. Anderson Cancer Center
Hypothesis
The study investigates the mechanisms by which anti-EGF receptor monoclonal antibodies induce apoptosis in DiFi human colon cancer cells.
Conclusion
The study found that anti-EGF receptor monoclonal antibodies induce apoptosis in DiFi cells through the activation of caspases, without involving c-jun N-terminal kinase activity.
Supporting Evidence
- Each of the tested anti-EGF receptor monoclonal antibodies induced apoptosis in DiFi cells.
- mAb 225 activated caspase-8 and caspase-9, leading to apoptosis.
- Pre-exposure to a caspase-3 inhibitor reduced apoptosis induced by mAb 225.
- mAb 225-induced apoptosis was not associated with activation of c-jun N-terminal kinase-1.
Takeaway
The researchers found that certain antibodies can make cancer cells die, and they figured out how this happens without using a specific pathway.
Methodology
The study involved exposing DiFi human colon cancer cells to different anti-EGF receptor monoclonal antibodies and measuring the activation of caspases and apoptosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website